Compounded Semaglutide vs Brand Name: Cost, Safety, and How to Choose

If you’ve spent any time in a weight-loss Facebook group or watched a sponsored Instagram ad, you’ve probably seen two very different numbers attached to the same drug. Brand-name Wegovy runs somewhere north of a thousand dollars a month without insurance. Compounded semaglutide from some online clinic is often a few hundred. Same molecule, wildly different price, and most patients have no idea why, or which one they’re actually being offered.

I get this question almost every week at Olympia Aesthetics & Wellness, usually from someone who found a cheaper option online and wants to know if it’s a scam before they commit. Sometimes it is. Sometimes it isn’t. The honest answer takes longer than a five-second Instagram caption, so here’s the full version.

What “compounded” actually means

Compounding is not inherently sketchy. It’s a legal, regulated practice where a licensed pharmacy prepares a medication for an individual patient based on a prescription, rather than manufacturing it at commercial scale like Novo Nordisk does for Ozempic and Wegovy. Compounding pharmacies have existed for decades, and they fill a real need: a patient who can’t tolerate a filler ingredient in the brand-name product, or who needs a dose strength that isn’t commercially available, can often get exactly what they need through a compounding pharmacy instead.

What changed the compounded semaglutide landscape wasn’t compounding itself. It was a shortage.

Where things stand now with the FDA

For a stretch of 2023 and into 2024, brand-name semaglutide was in short supply nationally. Under FDA rules, when a drug is on the official shortage list, compounding pharmacies get much more latitude to produce versions of it, because patients need access and the manufacturer can’t keep up. That’s the window that produced the flood of cheap compounded semaglutide you may remember from a couple years ago.

The FDA declared the semaglutide shortage resolved in February 2025. Once a drug comes off the shortage list, the broad compounding exception goes away with it. What’s left is a much narrower pathway under FDA rules known as Section 503A: a pharmacy can still compound a version of an available drug for a specific patient, but only when a prescriber determines and documents that the patient needs something meaningfully different from the commercial product, whether that’s a different strength, a different delivery method, or an ingredient change for an allergy. It has to be an individualized clinical decision, not a standing menu item offered to anyone who fills out an online form.

That distinction is the whole story. A legitimate compounding pharmacy filling a documented, patient-specific need is doing exactly what the law allows. A website offering the same product to every applicant after a four-question quiz, with no exam and no documented rationale, is operating in a gray zone the FDA has been actively sending warning letters about.

Brand-name semaglutide: what you actually pay

Novo Nordisk sells Wegovy directly to self-pay patients through its own savings program, and that published price is the cleanest benchmark available if you don’t have coverage. It has run in the neighborhood of $500 a month through the manufacturer’s direct pharmacy program, though Novo adjusts this periodically, so treat any number you read here, including this one, as a starting point to verify rather than a locked-in quote. Without any manufacturer assistance, the sticker price at a retail pharmacy counter runs well over $1,000. Ozempic, which is the same molecule approved for type 2 diabetes rather than weight management, follows a similar pattern with insurance coverage that depends heavily on your diagnosis.

Insurance coverage for weight-loss indications specifically is inconsistent. Some commercial plans cover it with prior authorization and documented BMI or a weight-related condition. Plenty of plans exclude anti-obesity medications as a category outright, and Medicare has historically not covered a GLP-1 prescribed purely for weight loss. If you have coverage, it’s worth a phone call to your insurer before you assume either way, since the person quoting you a number on social media has no idea what your specific plan actually covers.

What compounded semaglutide actually costs, and what you’re trading for the savings

Legitimate compounded semaglutide, sourced through a licensed US pharmacy and prescribed after a real evaluation, typically costs less than brand name, often in the range of $200 to $400 a month depending on dose and where you get it. That’s a real, meaningful savings, and it’s part of why patients ask about it.

The catch is quality control. Compounded medications are not FDA-approved products, meaning the FDA does not verify the potency, purity, or sterility of each batch the way it does for a commercially manufactured drug. A licensed compounding pharmacy operating under proper standards tests its products and follows strict sterile preparation protocols. A supplier operating outside that system, often overseas or through a loosely regulated online storefront, may not. The FDA has documented real cases of compounded semaglutide products containing incorrect concentrations, wrong salt forms of the drug, or contamination. Cheaper is not automatically the better deal when what you’re injecting into your body every week may not match what the label says.

A few practical red flags worth knowing before you order anything online:

  • No live consultation with a prescriber, or a consultation that’s clearly a formality before an automatic approval
  • No mention of which specific pharmacy is compounding the medication, or a pharmacy you can’t verify is licensed in your state
  • Pricing that seems dramatically lower than every other option you’ve seen, with no explanation of why
  • No baseline labs requested and no plan for follow-up monitoring as your dose increases

How we handle this at Olympia Aesthetics

Our semaglutide program uses a personalized formulation prepared by a licensed US pharmacy, the same 503A pathway described above, dosed and monitored the way the FDA framework actually intends it to work. That means an in-person consultation with Dr. Oliver Morris, baseline labs before you start, a documented clinical reason for the specific formulation you’re prescribed, and monthly follow-up visits as your dose titrates. It is not a five-question intake followed by a box in the mail.

We don’t publish one flat price because the program isn’t one-size. What we quote you at consultation reflects your labs, your starting point, and your expected dose, and it includes the visits and monitoring that a bargain-bin online supplier typically doesn’t. If you want to see how the numbers actually compare, including the specifics on brand-name pricing tiers, we broke that down in more detail for tirzepatide’s pricing structure, which follows a similar pattern to semaglutide.

Semaglutide or tirzepatide: does compounding change the choice

Whether you’re a better candidate for semaglutide or tirzepatide has nothing to do with brand versus compounded. That decision comes down to your biology, your goals, and how your body responds to each mechanism. We covered the clinical differences between the two medications, including who tends to do better on which one, in our guide to choosing between semaglutide and tirzepatide. The compounded-versus-brand question is really a separate decision about sourcing and oversight, not about which molecule is right for you.

The bottom line

Compounded semaglutide isn’t automatically a red flag, and brand-name isn’t automatically the safer choice just because it costs more. What actually matters is whether the medication came from a licensed pharmacy, whether a real prescriber made an individualized decision about your care, and whether anyone is watching your labs and your response as your dose changes. Price is the easiest thing to compare online and the least useful thing to base a decision on.

If you’re weighing your options and want an honest answer about what fits your situation, and not a sales pitch, call us at (727) 274-1972 or book a complimentary virtual consult at olympiaaesthetics.com/contact/. We’ll walk through your labs, your history, and your goals before anyone talks about a prescription.